Does baricitinib treat vitiligo?

Vitiligo is a common pigmented skin disorder characterized by patches of lack of pigment on the skin. The specific cause of vitiligo is unknown, but an autoimmune response is thought to play a role in its development. Although baricitinib has a certain role in immune regulation, there is currently insufficient scientific evidence to support its use in the treatment of vitiligo. At present, the treatment of vitiligo mainly includes local treatment (such as laser, topical hormones, etc.) and systemic treatment (such as phototherapy, oral drugs, etc.). The specific treatment method should be determined according to the patient's individual situation and the severity of the condition.